Practical Concept: Access to Pathogen Characterization and Clinical Support
1Physician or designated clinical coordinator contacts IDC regarding patient with complicated infection
2IDC clinical coordinator arranges receipt of medical charts, patient consent, and sample transfer
3Sample is analyzed in the Core Lab: Sensitivity to approved & clinical compounds, PK/PD, molecular characterization
4Medical staff examines lab results, patient case, and develops treatment protocol
4aIn cases where clinical stage drugs or expanded access programs are required, medical staff communicates with industry point of contact to determine eligibility
5Medical staff consults with treating physician; clinical coordinator assists in implementing protocols or eINDs
6Patient is treated; clinical outcomes are tracked; patient response may be analyzed by Core Lab characterization if needed